TCL Archive ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies June 5, 2009
TCL Archive NCI Advisors Criticize Plan To Fund R01s On ESA Research With Amgen, J&J Money. June 27, 2008